Obinutuzumab plus chemotherapy showed more durable efficacy, safety, and longer progression-free survival for patients with untreated follicular lymphoma.
In this study, skeletal muscle mass, as well as subcutaneous and visceral adiposity, were measured using CT imaging performed at baseline at the level of the L3 vertebrae.
Early detection of malnourishment in patients with gastric and esophageal adenocarcinoma identified as a strategy for improving outcomes for these patients.
Physicians noted that patients receiving best supportive care were more likely to be interested in low-intensity treatments if the risk for side effects was lower.
Results of a single-center retrospective study revealed that patients with darker pigmented skin frequently experienced irCAEs, therefore, increased surveillance is needed in SOC patients.
